Nuvation Bio Inc (NUVB) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE

Key Metrics

• Price: $5.80
• Market Cap: $1.91B
• EPS: $-0.49
• 52-Week High: $9.75
• 52-Week Low: $1.54

About Nuvation Bio Inc

Nuvation Bio Inc. is a clinical-stage biopharmaceutical company based in New York, focused on the development of innovative therapies for cancer treatment. The company is advancing a robust and diverse pipeline of drug candidates, addressing significant unmet medical needs in the oncology space. With an emphasis on precision medicine and the integration of novel therapeutic approaches, Nuvation Bio seeks to improve patient outcomes while positioning itself for substantial growth within the bi...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Nuvation Bio Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does NUVB pay dividends?

Nuvation Bio Inc (NUVB) does not currently pay a regular dividend.

What is NUVB's market cap?

Nuvation Bio Inc (NUVB) has a market capitalization of $1.91B with a current stock price of $5.80.